Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 377 to 426 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16758\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6704.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7811.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16461\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5246.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6109.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tar dna-binding protein-43 (tdp-43). [source:swissprot;acc:q13148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3658.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3144.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16358\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3641.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4236.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16339\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4e (eif-4e) (eif4e) (mrna cap-binding protein) (eif-4f 25 kda subunit). [source:swissprot;acc:p06730]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4490.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5222.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16301\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4532.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5269.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16251\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6563.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7627.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16205\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5367.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6233.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpa-binding protein 2 (hcnp protein) (pp3898). [source:swissprot;acc:q9hcs7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5084.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5904.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6603.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7664.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3594.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4169.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16015\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6644.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7707.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6744.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5815.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15974\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6647.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7706.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15927\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-terminal acetyltransferase complex ard1 subunit homolog (ec 2.3.1.-). [source:swissprot;acc:p41227]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4509.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5223.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15842\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-3 (bcl-2 binding athanogene- 3) (bag-3) (bcl-2-binding protein bis) (docking protein cair-1). [source:swissprot;acc:o95817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4522.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5233.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15708\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10235.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11830.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15589\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-2 protein. [source:swissprot;acc:p52735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6660.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7697.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15582\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5206.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15423\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3729.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4301.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pef protein with a long n-terminal hydrophobic domain (peflin). [source:refseq;acc:nm\_012392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6853.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15325\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/